| Literature DB >> 31671631 |
Yu-Meng Wang1, Xiao-Ku Ran2, Muhammad Riaz3,4, Miao Yu5, Qian Cai6, De-Qiang Dou7, Ahmed M Metwaly8,9, Ting-Guo Kang10, De-Cheng Cai11.
Abstract
Tagetespatula L. is a widely cultivated herbal medicinal plant in China and other countries. In this study, two new 2, 3-dihydrobenzofuran glucosides (1, 2) and fourteen known metabolites (3-16) were isolated from the stems and leaves of T. patula (SLT). The chemical structures of the isolated compounds were characterized comprehensively based on one- and two-dimensional NMR spectroscopy and high resolution mass spectrometry. Absolute configurations of compounds 1 and 2 were determined by ECD calculations. Compounds 1 and 2 exhibited moderate in vitro inhibitory activities against human gastric cancer cell lines (AGS) with IC50 values of 41.20 μmol/L and 30.43 μmol/L, respectively. The fingerprint profiles of stems and leaves of T. patula with three color types of flowers (Janie Yellow Bright, Jinmen Orange, Shouyao Red and Yellow color) were established by high-performance liquid chromatography (HPLC). Ten different batches of stems and leaves were examined as follow: Shouyao Red and Yellow color (1, 2, 3), Janie Yellow Bright (4, 5, 6, 7) and Jinmen Orange (8, 9, 10). Twenty-two common peaks were identified with similarity values ranging from 0.910 to 0.977. Meanwhile, the average peak area of SLT in the three types of flowers was different and it was the highest in Janie Yellow Bright.Entities:
Keywords: Tagetespatula L.; benzofurans; fingerprint; flavonoids
Mesh:
Substances:
Year: 2019 PMID: 31671631 PMCID: PMC6864839 DOI: 10.3390/molecules24213911
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure of the isolated compounds from T. patula.
Figure A1(a) Janie Yellow Bright, (b) Jinmen Orange, (c) Shouyao Red and Yellow color.
13C-NMR spectroscopic data of compounds 1 and 2 (500 MHz for 1H and 125 MHz for 13C data, J in Hz, recorded in CD3OD).
| Position | 1 | 2 | ||
|---|---|---|---|---|
| δC | δH | δC | δH | |
| 2 | 86.4 | 5.48 (1H, t, 8.5) | 90.0 | 5.27 (1H, d, 5.0) |
| 3 | 34.4 | 3.12 (1H, dd, 8.0, 15.5), 3.38 (1H, dd, 8.0, 15.5) | 81.0 | 5.33 (1H, d, 5.0) |
| 4 | 128.6 | 7.68 (1H, s) | 133.1 | 8.18 (1H, s) |
| 5 | 115.0 | 115.8 | ||
| 6 | 166.6 | 167.7 | ||
| 7 | 98.4 | 6.27 (1H, s) | 98.7 | 6.32 (1H, s) |
| 8 | 167.8 | 167.7 | ||
| 9 | 120.4 | 121.1 | ||
| 10 | 204.2 | 205.0 | ||
| 11 | 26.4 | 2.54 (3H, s) | 26.6 | 2.61 (3H, s) |
| 12 | 145.8 | 144.8 | ||
| 13 | 113.9 | 5.32 (1H, s), 5.28 (1H, s) | 114.5 | 5.36 (1H, s), 5.41 (1H, s) |
| 14 | 70.0 | 4.49 (1H, d, 10.0), 4.22 (1H, d,12.8) | 63.6 | 4.16 (1H, d, 15.0), 4.23 (1H, d, 10.0) |
| 1’ | 103.7 | 4.28 (1H, d, 4.3) | 105.5 | 4.54 (1H, d, 5.0) |
| 2’ | 75.1 | 3.35 (1H, m) | 75.3 | 3.17 (1H, dd, 5.0, 10.0) |
| 3’ | 78.1 | 3.40 (1H, m) | 78.4 | 3.36 (1H, s) |
| 4’ | 71.7 | 3.21 (1H, m) | 71.6 | 3.28 (1H, br s) |
| 5’ | 78.0 | 3.13 (1H, m) | 78.1 | 3.36 (1H, s) |
| 6’ | 62.83 | 3.25 (2H, m) | 62.8 | 3.73(1H, dd, 5.0, 10.0) 4.00 (1H, dd, 2.0, 11.5) |
Figure 2HMBC correlations of compounds 1 (a) and 2 (b).
Figure 3Caculated and experimental ECD spectra of compound 1 (a) and 2 (b).
HMBC spectroscopic data of compounds 1 and 2 (500 MHz for 1H and 125 MHz for 13C Data, J in Hz, recorded in CD3OD).
| Position | 1 | 2 | |||
|---|---|---|---|---|---|
| δH | HMBC | δH | HMBC | NOESY | |
| 2 | 5.48 (1H, t, 8.5) | C-3,C-9,C-12,C-13,C-14, | 5.17 (1H, d, 5.0) | C-12,C-13,C-14 | H-3,H-14, H-1’ |
| 3 | 3.12 (1H, dd, 8.0, 15.5), 3.38 (1H, dd, 8.0, 15.5) | C-2,C-4,C-8,C-9,C-12 | 5.33 (1H, d, 5.0) | C-1’,C-8 | H-3, H-4, H-13, H-14 |
| 4 | 7.68 (1H, s) | C-3, C-5, C-6, C-7, C-8, C-9 | 8.18 (1H, s) | C-8,C-10 | H-11, H-1’ |
| 5 | |||||
| 6 | |||||
| 7 | 6.27 (1H, s) | C-5,C-6,C-8,C-9 | 6.32 (1H, s) | C-5,C-6,C-9 | |
| 8 | |||||
| 9 | |||||
| 10 | |||||
| 11 | 2.54 (3H, s) | C-5, C-10 | 2.61 (3H, s) | C-5,C10 | |
| 12 | |||||
| 13 | 5.32 (1H, s), 5.28 (1H, s) | C-2, C-12, C-14 | 5.36 (1H, s), 5.41 (1H, s) | C-2,C12,C-14 | H-14 |
| 14 | 4.49 (1H, d, 10.0), 4.22 (1H, d, 12.8) | C-1’, C-2, C-12, C-13 | 4.16 (1H, d, 15.0), 4.23 (1H, d, 10.0) | C2,C-12,C-13 | H-2, H-13, H-1’ |
| 1’ | 4.28 (1H, d, 4.3) | C-14, C-2’ | 4.54 (1H, d, 5.0) | C-3 | H-3, H-4, H-14 |
| 2’ | 3.35 (1H, m) | C-1’, C-3’ | 3.17 (1H, dd, 5.0, 10.0) | C-1’, C-3’ | |
| 3’ | 3.40 (1H, m) | C-2’, C-4’ | 3.36 (1H, s) | C-2’ | |
| 4’ | 3.21 (1H, m) | C-3’, C-5’ | 3.28 (1H, br s) | C-3’, C-6’ | |
| 5’ | 3.13 (1H, m) | C-4’, C-5’, C-6’ | 3.36 (1H, s) | C-4’ | |
| 6’ | 3.25 (2H, m) | C-5’ | 3.73(1H, dd, 5.0, 10.0) 4.00 (1H, dd, 2.0, 11.5) | C-4’, C-5’ | H-4’ |
Figure 4The chromatographic fingerprint of 10 T. patula samples (S1–S10).
Figure 5Compound 12: Quercetin-3-O-α-L, arabinopyranoside; 13: kaempferol-3-O-β-D, glucoside; 14: kaempferol-3-O-α-L, arabinopyranoside; 15: kaempferol-3-O-β-D, xylopyranoside; 16: quercetin-7-O-α-L, rahmnoside; 17: kaempferol-7-O-α-L, rahmnoside; 18: patuletin; 19: kaempferol.
Relative peak area (RPA) of the common peaks of the T. patula.
| Peak No. | S1 | S2 | S3 | S4 | S5 | S6 | S7 | S8 | S9 | S10 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 0.425 | 0.416 | 0.940 | 0.425 | 0.243 | 0.468 | 0.594 | 0.130 | 0.712 | 0.468 |
| 7 | 0.806 | 0.694 | 1.092 | 0.560 | 0.432 | 0.718 | 0.977 | 0.283 | 0.596 | 0.485 |
| 11 | 0.824 | 1.674 | 2.878 | 1.901 | 0.707 | 1.756 | 2.523 | 1.001 | 1.740 | 1.166 |
| 12 | 0.373 | 1.116 | 1.377 | 0.898 | 0.346 | 0.897 | 1.239 | 0.483 | 0.628 | 0.440 |
| patuletin | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
| 20 | 0.388 | 1.841 | 1.934 | 2.137 | 0.683 | 1.966 | 3.057 | 1.223 | 1.626 | 2.995 |
| 22 | 0.201 | 1.304 | 1.673 | 1.079 | 0.697 | 1.234 | 2.072 | 0.370 | 0.928 | 0.303 |
| 24 | 0.289 | 2.620 | 2.942 | 1.918 | 0.721 | 2.037 | 3.036 | 0.369 | 1.102 | 0.558 |
| 25 | 0.468 | 0.629 | 1.320 | 1.244 | 0.696 | 0.658 | 0.702 | 0.362 | 1.819 | 0.839 |
Patuletin was taken as the reference peak to calculate RPA.
Evaluation results of 10 batches of T. patula samples.
| Similarity | S1 | S2 | S3 | S4 | S5 | S6 | S7 | S8 | S9 | S10 | R |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S1 | 1 | ||||||||||
| S2 | 0.825 | 1 | |||||||||
| S3 | 0.887 | 0.952 | 1 | ||||||||
| S4 | 0.876 | 0.954 | 0.933 | 1 | |||||||
| S5 | 0.894 | 0.907 | 0.892 | 0.926 | 1 | ||||||
| S6 | 0.868 | 0.944 | 0.927 | 0.949 | 0.943 | 1 | |||||
| S7 | 0.849 | 0.963 | 0.933 | 0.976 | 0.898 | 0.952 | 1 | ||||
| S8 | 0.884 | 0.882 | 0.874 | 0.922 | 0.946 | 0.939 | 0.897 | 1 | |||
| S9 | 0.921 | 0.879 | 0.952 | 0.911 | 0.906 | 0.897 | 0.878 | 0.895 | 1 | ||
| S10 | 0.785 | 0.845 | 0.825 | 0.872 | 0.858 | 0.884 | 0.841 | 0.928 | 0.855 | 1 | |
| R | 0.915 | 0.964 | 0.963 | 0.979 | 0.958 | 0.977 | 0.967 | 0.958 | 0.949 | 0.910 | 1 |
Analytical results of precision, stability, and repeatability rates of fourteen components in the T. patula.
| Peak No. | RSD of RPA (%) | RSD of RRT (%) | ||||
|---|---|---|---|---|---|---|
| Precision | Stability | Repeatability | Precision | Stability | Repeatability | |
| 5 | 4.397 | 4.769 | 3.401 | 0.492 | 0.458 | 0.246 |
| 6 | 3.504 | 5.883 | 1.574 | 0.321 | 0.238 | 0.258 |
| 11 | 3.343 | 6.253 | 3.652 | 0.375 | 0.522 | 0.586 |
| 15 | 4.840 | 4.976 | 4.701 | 0.125 | 0.131 | 0.098 |
| 18(S) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| 25 | 6.224 | 1.351 | 3.806 | 0.064 | 0.049 | 0.052 |
The human gastric cancer cell inhibitory activities of isolates.
| Compounds | IC50 (μmol/L) |
|---|---|
|
| 41.2 (25.94–70.53) |
| 30.4 (9.13–59.06) |
IC50 was afforded with confidence interval (n = 3); C.I., 95% confidence interval; positive control, 5-Fluorouracil.